Viewing Study NCT03645395


Ignite Creation Date: 2025-12-24 @ 1:35 PM
Ignite Modification Date: 2026-02-22 @ 4:50 PM
Study NCT ID: NCT03645395
Status: TERMINATED
Last Update Posted: 2022-08-16
First Post: 2018-07-19
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003)
Sponsor:
Organization: